nodes	percent_of_prediction	percent_of_DWPC	metapath
Ipratropium bromide—SLC22A5—Dactinomycin—germ cell cancer	0.413	0.662	CbGbCtD
Ipratropium bromide—CYP3A4—Ifosfamide—germ cell cancer	0.0741	0.119	CbGbCtD
Ipratropium bromide—CYP2D6—Vinblastine—germ cell cancer	0.0618	0.0992	CbGbCtD
Ipratropium bromide—CYP3A4—Vinblastine—germ cell cancer	0.0393	0.0631	CbGbCtD
Ipratropium bromide—CYP3A4—Etoposide—germ cell cancer	0.0354	0.0568	CbGbCtD
Ipratropium bromide—SLC22A4—Organic cation transport—SLC22A3—germ cell cancer	0.0144	0.198	CbGpPWpGaD
Ipratropium bromide—SLC22A5—Organic cation transport—SLC22A3—germ cell cancer	0.0108	0.149	CbGpPWpGaD
Ipratropium bromide—SLC22A4—Organic cation/anion/zwitterion transport—SLC22A3—germ cell cancer	0.00977	0.134	CbGpPWpGaD
Ipratropium bromide—SLC22A5—Organic cation/anion/zwitterion transport—SLC22A3—germ cell cancer	0.00734	0.101	CbGpPWpGaD
Ipratropium bromide—CHRM5—skin epidermis—germ cell cancer	0.00548	0.12	CbGeAlD
Ipratropium bromide—CYP3A4—urine—germ cell cancer	0.00208	0.0456	CbGeAlD
Ipratropium bromide—CYP2D6—urine—germ cell cancer	0.00205	0.0449	CbGeAlD
Ipratropium bromide—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.00199	0.0273	CbGpPWpGaD
Ipratropium bromide—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.00196	0.0269	CbGpPWpGaD
Ipratropium bromide—CHRM5—eye—germ cell cancer	0.00195	0.0428	CbGeAlD
Ipratropium bromide—SLC22A4—neck—germ cell cancer	0.00186	0.0408	CbGeAlD
Ipratropium bromide—CHRM5—skin of body—germ cell cancer	0.0017	0.0373	CbGeAlD
Ipratropium bromide—Pharyngitis—Vinblastine—germ cell cancer	0.00167	0.00648	CcSEcCtD
Ipratropium bromide—Urinary retention—Ifosfamide—germ cell cancer	0.00167	0.00647	CcSEcCtD
Ipratropium bromide—Nasal congestion—Cisplatin—germ cell cancer	0.00167	0.00644	CcSEcCtD
Ipratropium bromide—Dysphagia—Dactinomycin—germ cell cancer	0.00166	0.00642	CcSEcCtD
Ipratropium bromide—Lung disorder—Methotrexate—germ cell cancer	0.00162	0.00627	CcSEcCtD
Ipratropium bromide—Swelling—Etoposide—germ cell cancer	0.00158	0.00609	CcSEcCtD
Ipratropium bromide—Stomatitis—Bleomycin—germ cell cancer	0.00155	0.00598	CcSEcCtD
Ipratropium bromide—Bronchospasm—Ifosfamide—germ cell cancer	0.0015	0.00579	CcSEcCtD
Ipratropium bromide—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.00149	0.0206	CbGpPWpGaD
Ipratropium bromide—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.00147	0.0202	CbGpPWpGaD
Ipratropium bromide—Stomatitis—Dactinomycin—germ cell cancer	0.00144	0.00558	CcSEcCtD
Ipratropium bromide—Haemoglobin—Bleomycin—germ cell cancer	0.00143	0.00554	CcSEcCtD
Ipratropium bromide—Haemorrhage—Bleomycin—germ cell cancer	0.00143	0.00551	CcSEcCtD
Ipratropium bromide—Dysuria—Ifosfamide—germ cell cancer	0.00142	0.0055	CcSEcCtD
Ipratropium bromide—Hypoaesthesia—Bleomycin—germ cell cancer	0.00142	0.00548	CcSEcCtD
Ipratropium bromide—Pollakiuria—Ifosfamide—germ cell cancer	0.00141	0.00543	CcSEcCtD
Ipratropium bromide—Neuropathy peripheral—Ifosfamide—germ cell cancer	0.00133	0.00514	CcSEcCtD
Ipratropium bromide—Flushing—Bleomycin—germ cell cancer	0.00132	0.00511	CcSEcCtD
Ipratropium bromide—Stomatitis—Ifosfamide—germ cell cancer	0.00132	0.00511	CcSEcCtD
Ipratropium bromide—Pharyngitis—Dactinomycin—germ cell cancer	0.00132	0.0051	CcSEcCtD
Ipratropium bromide—Conjunctivitis—Ifosfamide—germ cell cancer	0.00132	0.0051	CcSEcCtD
Ipratropium bromide—Hypertension—Vinblastine—germ cell cancer	0.00127	0.0049	CcSEcCtD
Ipratropium bromide—Abdominal discomfort—Cisplatin—germ cell cancer	0.00126	0.00486	CcSEcCtD
Ipratropium bromide—Flushing—Dactinomycin—germ cell cancer	0.00123	0.00477	CcSEcCtD
Ipratropium bromide—Haemoglobin—Ifosfamide—germ cell cancer	0.00122	0.00473	CcSEcCtD
Ipratropium bromide—CHRM2—telencephalon—germ cell cancer	0.00122	0.0268	CbGeAlD
Ipratropium bromide—Haemorrhage—Ifosfamide—germ cell cancer	0.00122	0.00471	CcSEcCtD
Ipratropium bromide—Ulcer—Methotrexate—germ cell cancer	0.00121	0.00469	CcSEcCtD
Ipratropium bromide—Urinary tract disorder—Ifosfamide—germ cell cancer	0.0012	0.00465	CcSEcCtD
Ipratropium bromide—Dysphagia—Etoposide—germ cell cancer	0.0012	0.00465	CcSEcCtD
Ipratropium bromide—SLC22A4—decidua—germ cell cancer	0.00119	0.0262	CbGeAlD
Ipratropium bromide—Urethral disorder—Ifosfamide—germ cell cancer	0.00119	0.00462	CcSEcCtD
Ipratropium bromide—Inflammation—Methotrexate—germ cell cancer	0.00118	0.00457	CcSEcCtD
Ipratropium bromide—Bronchospasm—Etoposide—germ cell cancer	0.00118	0.00457	CcSEcCtD
Ipratropium bromide—Visual impairment—Ifosfamide—germ cell cancer	0.00117	0.00454	CcSEcCtD
Ipratropium bromide—Neuropathy peripheral—Cisplatin—germ cell cancer	0.00115	0.00443	CcSEcCtD
Ipratropium bromide—Stomatitis—Cisplatin—germ cell cancer	0.00114	0.00441	CcSEcCtD
Ipratropium bromide—Eye disorder—Ifosfamide—germ cell cancer	0.00114	0.0044	CcSEcCtD
Ipratropium bromide—Conjunctivitis—Cisplatin—germ cell cancer	0.00114	0.0044	CcSEcCtD
Ipratropium bromide—Tinnitus—Ifosfamide—germ cell cancer	0.00114	0.00439	CcSEcCtD
Ipratropium bromide—Cardiac disorder—Ifosfamide—germ cell cancer	0.00113	0.00437	CcSEcCtD
Ipratropium bromide—Flushing—Ifosfamide—germ cell cancer	0.00113	0.00437	CcSEcCtD
Ipratropium bromide—CHRM1—telencephalon—germ cell cancer	0.00111	0.0244	CbGeAlD
Ipratropium bromide—CYP2D6—Metapathway biotransformation—NAT9—germ cell cancer	0.00111	0.0153	CbGpPWpGaD
Ipratropium bromide—CHRM5—head—germ cell cancer	0.00111	0.0243	CbGeAlD
Ipratropium bromide—Immune system disorder—Ifosfamide—germ cell cancer	0.0011	0.00425	CcSEcCtD
Ipratropium bromide—Mediastinal disorder—Ifosfamide—germ cell cancer	0.0011	0.00424	CcSEcCtD
Ipratropium bromide—Cough—Bleomycin—germ cell cancer	0.00108	0.00419	CcSEcCtD
Ipratropium bromide—Paraesthesia—Vinblastine—germ cell cancer	0.00108	0.00416	CcSEcCtD
Ipratropium bromide—SLC22A5—trigeminal ganglion—germ cell cancer	0.00106	0.0233	CbGeAlD
Ipratropium bromide—Chest pain—Bleomycin—germ cell cancer	0.00106	0.00408	CcSEcCtD
Ipratropium bromide—Myalgia—Bleomycin—germ cell cancer	0.00106	0.00408	CcSEcCtD
Ipratropium bromide—Neuropathy peripheral—Etoposide—germ cell cancer	0.00105	0.00406	CcSEcCtD
Ipratropium bromide—Stomatitis—Etoposide—germ cell cancer	0.00104	0.00404	CcSEcCtD
Ipratropium bromide—Urinary tract disorder—Cisplatin—germ cell cancer	0.00104	0.00401	CcSEcCtD
Ipratropium bromide—Urethral disorder—Cisplatin—germ cell cancer	0.00103	0.00398	CcSEcCtD
Ipratropium bromide—SLC22A4—pituitary gland—germ cell cancer	0.00103	0.0225	CbGeAlD
Ipratropium bromide—Pain—Vinblastine—germ cell cancer	0.00103	0.00396	CcSEcCtD
Ipratropium bromide—Constipation—Vinblastine—germ cell cancer	0.00103	0.00396	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Bleomycin—germ cell cancer	0.00101	0.00391	CcSEcCtD
Ipratropium bromide—Oedema—Bleomycin—germ cell cancer	0.00101	0.00391	CcSEcCtD
Ipratropium bromide—Visual impairment—Cisplatin—germ cell cancer	0.00101	0.00391	CcSEcCtD
Ipratropium bromide—Infection—Bleomycin—germ cell cancer	0.00101	0.00389	CcSEcCtD
Ipratropium bromide—Vision blurred—Ifosfamide—germ cell cancer	0.000999	0.00386	CcSEcCtD
Ipratropium bromide—CHRM3—telencephalon—germ cell cancer	0.000995	0.0218	CbGeAlD
Ipratropium bromide—Myalgia—Dactinomycin—germ cell cancer	0.000985	0.00381	CcSEcCtD
Ipratropium bromide—Eye disorder—Cisplatin—germ cell cancer	0.000981	0.00379	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Vinblastine—germ cell cancer	0.00098	0.00379	CcSEcCtD
Ipratropium bromide—Tinnitus—Cisplatin—germ cell cancer	0.000979	0.00379	CcSEcCtD
Ipratropium bromide—Cardiac disorder—Cisplatin—germ cell cancer	0.000974	0.00377	CcSEcCtD
Ipratropium bromide—Flushing—Cisplatin—germ cell cancer	0.000974	0.00377	CcSEcCtD
Ipratropium bromide—Angioedema—Ifosfamide—germ cell cancer	0.000969	0.00375	CcSEcCtD
Ipratropium bromide—Hypoaesthesia—Etoposide—germ cell cancer	0.000957	0.0037	CcSEcCtD
Ipratropium bromide—Urinary tract disorder—Etoposide—germ cell cancer	0.00095	0.00367	CcSEcCtD
Ipratropium bromide—Immune system disorder—Cisplatin—germ cell cancer	0.000948	0.00367	CcSEcCtD
Ipratropium bromide—Abdominal pain—Vinblastine—germ cell cancer	0.000948	0.00366	CcSEcCtD
Ipratropium bromide—Mediastinal disorder—Cisplatin—germ cell cancer	0.000946	0.00366	CcSEcCtD
Ipratropium bromide—Hypotension—Bleomycin—germ cell cancer	0.000946	0.00366	CcSEcCtD
Ipratropium bromide—Oedema—Dactinomycin—germ cell cancer	0.000944	0.00365	CcSEcCtD
Ipratropium bromide—Urethral disorder—Etoposide—germ cell cancer	0.000943	0.00365	CcSEcCtD
Ipratropium bromide—Infection—Dactinomycin—germ cell cancer	0.000938	0.00363	CcSEcCtD
Ipratropium bromide—Palpitations—Ifosfamide—germ cell cancer	0.000937	0.00362	CcSEcCtD
Ipratropium bromide—Cough—Ifosfamide—germ cell cancer	0.000925	0.00358	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.000922	0.00357	CcSEcCtD
Ipratropium bromide—SLC22A4—adrenal gland—germ cell cancer	0.000916	0.0201	CbGeAlD
Ipratropium bromide—Hypertension—Ifosfamide—germ cell cancer	0.000915	0.00354	CcSEcCtD
Ipratropium bromide—Paraesthesia—Bleomycin—germ cell cancer	0.000909	0.00352	CcSEcCtD
Ipratropium bromide—SLC22A5—retina—germ cell cancer	0.000906	0.0199	CbGeAlD
Ipratropium bromide—SLC22A4—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000903	0.0124	CbGpPWpGaD
Ipratropium bromide—Dyspnoea—Bleomycin—germ cell cancer	0.000903	0.00349	CcSEcCtD
Ipratropium bromide—Chest pain—Ifosfamide—germ cell cancer	0.000903	0.00349	CcSEcCtD
Ipratropium bromide—Myalgia—Ifosfamide—germ cell cancer	0.000903	0.00349	CcSEcCtD
Ipratropium bromide—Flatulence—Cisplatin—germ cell cancer	0.000901	0.00348	CcSEcCtD
Ipratropium bromide—Eye disorder—Etoposide—germ cell cancer	0.000899	0.00348	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.000896	0.00347	CcSEcCtD
Ipratropium bromide—Flushing—Etoposide—germ cell cancer	0.000893	0.00345	CcSEcCtD
Ipratropium bromide—Cardiac disorder—Etoposide—germ cell cancer	0.000893	0.00345	CcSEcCtD
Ipratropium bromide—SLC22A4—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000889	0.0122	CbGpPWpGaD
Ipratropium bromide—SLC22A4—bone marrow—germ cell cancer	0.000886	0.0195	CbGeAlD
Ipratropium bromide—Hypersensitivity—Vinblastine—germ cell cancer	0.000883	0.00341	CcSEcCtD
Ipratropium bromide—SLC22A4—spinal cord—germ cell cancer	0.000883	0.0194	CbGeAlD
Ipratropium bromide—Immune system disorder—Etoposide—germ cell cancer	0.000869	0.00336	CcSEcCtD
Ipratropium bromide—Mediastinal disorder—Etoposide—germ cell cancer	0.000867	0.00335	CcSEcCtD
Ipratropium bromide—Pain—Bleomycin—germ cell cancer	0.000866	0.00335	CcSEcCtD
Ipratropium bromide—Oedema—Ifosfamide—germ cell cancer	0.000865	0.00335	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Ifosfamide—germ cell cancer	0.000865	0.00335	CcSEcCtD
Ipratropium bromide—Vision blurred—Cisplatin—germ cell cancer	0.000861	0.00333	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.00086	0.00333	CcSEcCtD
Ipratropium bromide—Asthenia—Vinblastine—germ cell cancer	0.00086	0.00333	CcSEcCtD
Ipratropium bromide—Infection—Ifosfamide—germ cell cancer	0.00086	0.00332	CcSEcCtD
Ipratropium bromide—Tremor—Cisplatin—germ cell cancer	0.000856	0.00331	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Ifosfamide—germ cell cancer	0.000849	0.00328	CcSEcCtD
Ipratropium bromide—Skin disorder—Ifosfamide—germ cell cancer	0.00084	0.00325	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Ifosfamide—germ cell cancer	0.000836	0.00323	CcSEcCtD
Ipratropium bromide—Diarrhoea—Vinblastine—germ cell cancer	0.00082	0.00317	CcSEcCtD
Ipratropium bromide—Dysgeusia—Etoposide—germ cell cancer	0.00082	0.00317	CcSEcCtD
Ipratropium bromide—Fatigue—Dactinomycin—germ cell cancer	0.000814	0.00315	CcSEcCtD
Ipratropium bromide—Back pain—Etoposide—germ cell cancer	0.00081	0.00313	CcSEcCtD
Ipratropium bromide—Hypotension—Ifosfamide—germ cell cancer	0.000809	0.00313	CcSEcCtD
Ipratropium bromide—Pain—Dactinomycin—germ cell cancer	0.000807	0.00312	CcSEcCtD
Ipratropium bromide—Urticaria—Bleomycin—germ cell cancer	0.000804	0.00311	CcSEcCtD
Ipratropium bromide—CHRM5—brain—germ cell cancer	0.000803	0.0176	CbGeAlD
Ipratropium bromide—CHRM2—SIDS Susceptibility Pathways—NANOG—germ cell cancer	0.000803	0.011	CbGpPWpGaD
Ipratropium bromide—SLC22A5—skin of body—germ cell cancer	0.000796	0.0175	CbGeAlD
Ipratropium bromide—Dizziness—Vinblastine—germ cell cancer	0.000793	0.00307	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.000788	0.00305	CcSEcCtD
Ipratropium bromide—Myalgia—Cisplatin—germ cell cancer	0.000778	0.00301	CcSEcCtD
Ipratropium bromide—Paraesthesia—Ifosfamide—germ cell cancer	0.000777	0.003	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.000773	0.00299	CcSEcCtD
Ipratropium bromide—CHRM2—SIDS Susceptibility Pathways—POU5F1—germ cell cancer	0.000773	0.0106	CbGpPWpGaD
Ipratropium bromide—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000772	0.00299	CcSEcCtD
Ipratropium bromide—Dyspnoea—Ifosfamide—germ cell cancer	0.000771	0.00298	CcSEcCtD
Ipratropium bromide—CHRM2—endocrine gland—germ cell cancer	0.00077	0.0169	CbGeAlD
Ipratropium bromide—Somnolence—Ifosfamide—germ cell cancer	0.000769	0.00297	CcSEcCtD
Ipratropium bromide—Vomiting—Vinblastine—germ cell cancer	0.000762	0.00295	CcSEcCtD
Ipratropium bromide—CHRM2—head—germ cell cancer	0.00076	0.0167	CbGeAlD
Ipratropium bromide—Headache—Vinblastine—germ cell cancer	0.000751	0.0029	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000747	0.00289	CcSEcCtD
Ipratropium bromide—Abdominal pain—Dactinomycin—germ cell cancer	0.000746	0.00289	CcSEcCtD
Ipratropium bromide—Fatigue—Ifosfamide—germ cell cancer	0.000746	0.00288	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Cisplatin—germ cell cancer	0.000746	0.00288	CcSEcCtD
Ipratropium bromide—Oedema—Cisplatin—germ cell cancer	0.000746	0.00288	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Bleomycin—germ cell cancer	0.000746	0.00288	CcSEcCtD
Ipratropium bromide—Infection—Cisplatin—germ cell cancer	0.000741	0.00287	CcSEcCtD
Ipratropium bromide—Constipation—Ifosfamide—germ cell cancer	0.00074	0.00286	CcSEcCtD
Ipratropium bromide—Pain—Ifosfamide—germ cell cancer	0.00074	0.00286	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Cisplatin—germ cell cancer	0.000732	0.00283	CcSEcCtD
Ipratropium bromide—Cough—Etoposide—germ cell cancer	0.000731	0.00283	CcSEcCtD
Ipratropium bromide—Tachycardia—Cisplatin—germ cell cancer	0.000728	0.00282	CcSEcCtD
Ipratropium bromide—Asthenia—Bleomycin—germ cell cancer	0.000726	0.00281	CcSEcCtD
Ipratropium bromide—CYP3A4—Metapathway biotransformation—NAT9—germ cell cancer	0.000726	0.00999	CbGpPWpGaD
Ipratropium bromide—Skin disorder—Cisplatin—germ cell cancer	0.000725	0.0028	CcSEcCtD
Ipratropium bromide—Hypertension—Etoposide—germ cell cancer	0.000723	0.0028	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Cisplatin—germ cell cancer	0.000721	0.00279	CcSEcCtD
Ipratropium bromide—Asthma—Methotrexate—germ cell cancer	0.00072	0.00278	CcSEcCtD
Ipratropium bromide—Pruritus—Bleomycin—germ cell cancer	0.000716	0.00277	CcSEcCtD
Ipratropium bromide—Chest pain—Etoposide—germ cell cancer	0.000713	0.00276	CcSEcCtD
Ipratropium bromide—Nausea—Vinblastine—germ cell cancer	0.000712	0.00275	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.000708	0.00274	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000708	0.00274	CcSEcCtD
Ipratropium bromide—SLC22A4—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000701	0.00965	CbGpPWpGaD
Ipratropium bromide—CHRM1—endocrine gland—germ cell cancer	0.000701	0.0154	CbGeAlD
Ipratropium bromide—SLC22A4—cerebellum—germ cell cancer	0.0007	0.0154	CbGeAlD
Ipratropium bromide—Hypotension—Cisplatin—germ cell cancer	0.000697	0.0027	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Dactinomycin—germ cell cancer	0.000696	0.00269	CcSEcCtD
Ipratropium bromide—CHRM1—head—germ cell cancer	0.000692	0.0152	CbGeAlD
Ipratropium bromide—Abdominal discomfort—Methotrexate—germ cell cancer	0.00069	0.00267	CcSEcCtD
Ipratropium bromide—Urticaria—Ifosfamide—germ cell cancer	0.000687	0.00266	CcSEcCtD
Ipratropium bromide—Abdominal pain—Ifosfamide—germ cell cancer	0.000684	0.00264	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Etoposide—germ cell cancer	0.000683	0.00264	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.00068	0.00263	CcSEcCtD
Ipratropium bromide—Infection—Etoposide—germ cell cancer	0.000679	0.00263	CcSEcCtD
Ipratropium bromide—SLC22A5—pituitary gland—germ cell cancer	0.000679	0.0149	CbGeAlD
Ipratropium bromide—SLC22A5—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000678	0.00934	CbGpPWpGaD
Ipratropium bromide—Asthenia—Dactinomycin—germ cell cancer	0.000677	0.00262	CcSEcCtD
Ipratropium bromide—CHRM3—female gonad—germ cell cancer	0.000675	0.0148	CbGeAlD
Ipratropium bromide—Dysuria—Methotrexate—germ cell cancer	0.000673	0.0026	CcSEcCtD
Ipratropium bromide—Paraesthesia—Cisplatin—germ cell cancer	0.00067	0.00259	CcSEcCtD
Ipratropium bromide—Upper respiratory tract infection—Methotrexate—germ cell cancer	0.000669	0.00259	CcSEcCtD
Ipratropium bromide—SLC22A5—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000668	0.0092	CbGpPWpGaD
Ipratropium bromide—Tachycardia—Etoposide—germ cell cancer	0.000667	0.00258	CcSEcCtD
Ipratropium bromide—Dyspnoea—Cisplatin—germ cell cancer	0.000665	0.00257	CcSEcCtD
Ipratropium bromide—Skin disorder—Etoposide—germ cell cancer	0.000664	0.00257	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Etoposide—germ cell cancer	0.000661	0.00255	CcSEcCtD
Ipratropium bromide—SLC22A5—medulla oblongata—germ cell cancer	0.000655	0.0144	CbGeAlD
Ipratropium bromide—Diarrhoea—Dactinomycin—germ cell cancer	0.000646	0.0025	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000644	0.00249	CcSEcCtD
Ipratropium bromide—Vomiting—Bleomycin—germ cell cancer	0.000644	0.00249	CcSEcCtD
Ipratropium bromide—Hypotension—Etoposide—germ cell cancer	0.000639	0.00247	CcSEcCtD
Ipratropium bromide—Rash—Bleomycin—germ cell cancer	0.000638	0.00247	CcSEcCtD
Ipratropium bromide—Pain—Cisplatin—germ cell cancer	0.000638	0.00247	CcSEcCtD
Ipratropium bromide—Dermatitis—Bleomycin—germ cell cancer	0.000638	0.00247	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Ifosfamide—germ cell cancer	0.000638	0.00246	CcSEcCtD
Ipratropium bromide—CHRM3—endocrine gland—germ cell cancer	0.000627	0.0138	CbGeAlD
Ipratropium bromide—Stomatitis—Methotrexate—germ cell cancer	0.000626	0.00242	CcSEcCtD
Ipratropium bromide—Conjunctivitis—Methotrexate—germ cell cancer	0.000624	0.00241	CcSEcCtD
Ipratropium bromide—Asthenia—Ifosfamide—germ cell cancer	0.000621	0.0024	CcSEcCtD
Ipratropium bromide—CHRM3—head—germ cell cancer	0.000619	0.0136	CbGeAlD
Ipratropium bromide—Sweating—Methotrexate—germ cell cancer	0.000615	0.00238	CcSEcCtD
Ipratropium bromide—Paraesthesia—Etoposide—germ cell cancer	0.000614	0.00237	CcSEcCtD
Ipratropium bromide—Pruritus—Ifosfamide—germ cell cancer	0.000612	0.00237	CcSEcCtD
Ipratropium bromide—Dyspnoea—Etoposide—germ cell cancer	0.000609	0.00236	CcSEcCtD
Ipratropium bromide—Somnolence—Etoposide—germ cell cancer	0.000608	0.00235	CcSEcCtD
Ipratropium bromide—SLC22A5—adrenal gland—germ cell cancer	0.000606	0.0133	CbGeAlD
Ipratropium bromide—CYP2D6—brainstem—germ cell cancer	0.000606	0.0133	CbGeAlD
Ipratropium bromide—Epistaxis—Methotrexate—germ cell cancer	0.000605	0.00234	CcSEcCtD
Ipratropium bromide—Nausea—Bleomycin—germ cell cancer	0.000601	0.00233	CcSEcCtD
Ipratropium bromide—Vomiting—Dactinomycin—germ cell cancer	0.0006	0.00232	CcSEcCtD
Ipratropium bromide—SLC22A5—midbrain—germ cell cancer	0.000599	0.0131	CbGeAlD
Ipratropium bromide—CHRM3—testis—germ cell cancer	0.000598	0.0131	CbGeAlD
Ipratropium bromide—Rash—Dactinomycin—germ cell cancer	0.000595	0.0023	CcSEcCtD
Ipratropium bromide—Diarrhoea—Ifosfamide—germ cell cancer	0.000592	0.00229	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Etoposide—germ cell cancer	0.00059	0.00228	CcSEcCtD
Ipratropium bromide—Fatigue—Etoposide—germ cell cancer	0.000589	0.00228	CcSEcCtD
Ipratropium bromide—Pain—Etoposide—germ cell cancer	0.000584	0.00226	CcSEcCtD
Ipratropium bromide—Constipation—Etoposide—germ cell cancer	0.000584	0.00226	CcSEcCtD
Ipratropium bromide—SLC22A5—spinal cord—germ cell cancer	0.000584	0.0128	CbGeAlD
Ipratropium bromide—Haemoglobin—Methotrexate—germ cell cancer	0.000579	0.00224	CcSEcCtD
Ipratropium bromide—Haemorrhage—Methotrexate—germ cell cancer	0.000576	0.00223	CcSEcCtD
Ipratropium bromide—Dizziness—Ifosfamide—germ cell cancer	0.000572	0.00221	CcSEcCtD
Ipratropium bromide—Pharyngitis—Methotrexate—germ cell cancer	0.000572	0.00221	CcSEcCtD
Ipratropium bromide—Urinary tract disorder—Methotrexate—germ cell cancer	0.000569	0.0022	CcSEcCtD
Ipratropium bromide—SLC22A4—brain—germ cell cancer	0.000568	0.0125	CbGeAlD
Ipratropium bromide—SLC22A5—female gonad—germ cell cancer	0.000565	0.0124	CbGeAlD
Ipratropium bromide—Urethral disorder—Methotrexate—germ cell cancer	0.000565	0.00218	CcSEcCtD
Ipratropium bromide—Nausea—Dactinomycin—germ cell cancer	0.000561	0.00217	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Etoposide—germ cell cancer	0.000559	0.00216	CcSEcCtD
Ipratropium bromide—Visual impairment—Methotrexate—germ cell cancer	0.000555	0.00215	CcSEcCtD
Ipratropium bromide—CHRM2—brain—germ cell cancer	0.000551	0.0121	CbGeAlD
Ipratropium bromide—Vomiting—Ifosfamide—germ cell cancer	0.00055	0.00213	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Cisplatin—germ cell cancer	0.00055	0.00213	CcSEcCtD
Ipratropium bromide—SLC22A4—lymph node—germ cell cancer	0.000549	0.0121	CbGeAlD
Ipratropium bromide—Rash—Ifosfamide—germ cell cancer	0.000546	0.00211	CcSEcCtD
Ipratropium bromide—Dermatitis—Ifosfamide—germ cell cancer	0.000545	0.00211	CcSEcCtD
Ipratropium bromide—Urticaria—Etoposide—germ cell cancer	0.000543	0.0021	CcSEcCtD
Ipratropium bromide—Abdominal pain—Etoposide—germ cell cancer	0.00054	0.00209	CcSEcCtD
Ipratropium bromide—Eye disorder—Methotrexate—germ cell cancer	0.000538	0.00208	CcSEcCtD
Ipratropium bromide—CYP2D6—telencephalon—germ cell cancer	0.000538	0.0118	CbGeAlD
Ipratropium bromide—Tinnitus—Methotrexate—germ cell cancer	0.000537	0.00208	CcSEcCtD
Ipratropium bromide—Asthenia—Cisplatin—germ cell cancer	0.000535	0.00207	CcSEcCtD
Ipratropium bromide—Cardiac disorder—Methotrexate—germ cell cancer	0.000535	0.00207	CcSEcCtD
Ipratropium bromide—SLC22A5—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000527	0.00725	CbGpPWpGaD
Ipratropium bromide—Immune system disorder—Methotrexate—germ cell cancer	0.00052	0.00201	CcSEcCtD
Ipratropium bromide—Mediastinal disorder—Methotrexate—germ cell cancer	0.000519	0.00201	CcSEcCtD
Ipratropium bromide—Nausea—Ifosfamide—germ cell cancer	0.000514	0.00199	CcSEcCtD
Ipratropium bromide—Diarrhoea—Cisplatin—germ cell cancer	0.00051	0.00197	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Etoposide—germ cell cancer	0.000504	0.00195	CcSEcCtD
Ipratropium bromide—CHRM1—brain—germ cell cancer	0.000502	0.011	CbGeAlD
Ipratropium bromide—SLC22A5—testis—germ cell cancer	0.000501	0.011	CbGeAlD
Ipratropium bromide—Dysgeusia—Methotrexate—germ cell cancer	0.000491	0.0019	CcSEcCtD
Ipratropium bromide—Asthenia—Etoposide—germ cell cancer	0.00049	0.0019	CcSEcCtD
Ipratropium bromide—Back pain—Methotrexate—germ cell cancer	0.000485	0.00188	CcSEcCtD
Ipratropium bromide—Pruritus—Etoposide—germ cell cancer	0.000484	0.00187	CcSEcCtD
Ipratropium bromide—Vomiting—Cisplatin—germ cell cancer	0.000474	0.00183	CcSEcCtD
Ipratropium bromide—Vision blurred—Methotrexate—germ cell cancer	0.000473	0.00183	CcSEcCtD
Ipratropium bromide—Rash—Cisplatin—germ cell cancer	0.00047	0.00182	CcSEcCtD
Ipratropium bromide—Dermatitis—Cisplatin—germ cell cancer	0.00047	0.00182	CcSEcCtD
Ipratropium bromide—CHRM5—Regulation of Actin Cytoskeleton—FGF4—germ cell cancer	0.00047	0.00646	CbGpPWpGaD
Ipratropium bromide—Diarrhoea—Etoposide—germ cell cancer	0.000468	0.00181	CcSEcCtD
Ipratropium bromide—SLC22A5—cerebellum—germ cell cancer	0.000463	0.0102	CbGeAlD
Ipratropium bromide—CHRM5—G alpha (q) signalling events—OXT—germ cell cancer	0.000459	0.00631	CbGpPWpGaD
Ipratropium bromide—SLC22A4—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000459	0.00631	CbGpPWpGaD
Ipratropium bromide—Dizziness—Etoposide—germ cell cancer	0.000452	0.00175	CcSEcCtD
Ipratropium bromide—SLC22A4—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000452	0.00622	CbGpPWpGaD
Ipratropium bromide—CHRM3—brain—germ cell cancer	0.000449	0.00985	CbGeAlD
Ipratropium bromide—Nausea—Cisplatin—germ cell cancer	0.000443	0.00171	CcSEcCtD
Ipratropium bromide—Cough—Methotrexate—germ cell cancer	0.000438	0.00169	CcSEcCtD
Ipratropium bromide—Vomiting—Etoposide—germ cell cancer	0.000435	0.00168	CcSEcCtD
Ipratropium bromide—Rash—Etoposide—germ cell cancer	0.000431	0.00167	CcSEcCtD
Ipratropium bromide—Dermatitis—Etoposide—germ cell cancer	0.000431	0.00166	CcSEcCtD
Ipratropium bromide—CHRM2—SIDS Susceptibility Pathways—SOX2—germ cell cancer	0.000429	0.0059	CbGpPWpGaD
Ipratropium bromide—Headache—Etoposide—germ cell cancer	0.000428	0.00166	CcSEcCtD
Ipratropium bromide—Myalgia—Methotrexate—germ cell cancer	0.000427	0.00165	CcSEcCtD
Ipratropium bromide—Chest pain—Methotrexate—germ cell cancer	0.000427	0.00165	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000424	0.00164	CcSEcCtD
Ipratropium bromide—SLC22A4—SLC-mediated transmembrane transport—AVP—germ cell cancer	0.000416	0.00573	CbGpPWpGaD
Ipratropium bromide—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—OXT—germ cell cancer	0.00041	0.00565	CbGpPWpGaD
Ipratropium bromide—Anaphylactic shock—Methotrexate—germ cell cancer	0.000409	0.00158	CcSEcCtD
Ipratropium bromide—Infection—Methotrexate—germ cell cancer	0.000407	0.00157	CcSEcCtD
Ipratropium bromide—Nausea—Etoposide—germ cell cancer	0.000406	0.00157	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Methotrexate—germ cell cancer	0.000401	0.00155	CcSEcCtD
Ipratropium bromide—Skin disorder—Methotrexate—germ cell cancer	0.000398	0.00154	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Methotrexate—germ cell cancer	0.000396	0.00153	CcSEcCtD
Ipratropium bromide—Hypotension—Methotrexate—germ cell cancer	0.000383	0.00148	CcSEcCtD
Ipratropium bromide—SLC22A5—brain—germ cell cancer	0.000376	0.00825	CbGeAlD
Ipratropium bromide—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000373	0.00144	CcSEcCtD
Ipratropium bromide—Insomnia—Methotrexate—germ cell cancer	0.00037	0.00143	CcSEcCtD
Ipratropium bromide—Paraesthesia—Methotrexate—germ cell cancer	0.000368	0.00142	CcSEcCtD
Ipratropium bromide—Dyspnoea—Methotrexate—germ cell cancer	0.000365	0.00141	CcSEcCtD
Ipratropium bromide—CYP2D6—female gonad—germ cell cancer	0.000365	0.008	CbGeAlD
Ipratropium bromide—Somnolence—Methotrexate—germ cell cancer	0.000364	0.00141	CcSEcCtD
Ipratropium bromide—SLC22A5—lymph node—germ cell cancer	0.000363	0.00798	CbGeAlD
Ipratropium bromide—Dyspepsia—Methotrexate—germ cell cancer	0.00036	0.00139	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000353	0.00137	CcSEcCtD
Ipratropium bromide—Fatigue—Methotrexate—germ cell cancer	0.000353	0.00136	CcSEcCtD
Ipratropium bromide—Pain—Methotrexate—germ cell cancer	0.00035	0.00135	CcSEcCtD
Ipratropium bromide—SLC22A5—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000345	0.00475	CbGpPWpGaD
Ipratropium bromide—CYP3A4—endocrine gland—germ cell cancer	0.000345	0.00757	CbGeAlD
Ipratropium bromide—SLC22A5—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.00034	0.00467	CbGpPWpGaD
Ipratropium bromide—CYP2D6—endocrine gland—germ cell cancer	0.000339	0.00744	CbGeAlD
Ipratropium bromide—CYP2D6—head—germ cell cancer	0.000335	0.00735	CbGeAlD
Ipratropium bromide—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000335	0.00129	CcSEcCtD
Ipratropium bromide—CHRM1—Regulation of Actin Cytoskeleton—FGF4—germ cell cancer	0.000331	0.00455	CbGpPWpGaD
Ipratropium bromide—CHRM3—Regulation of Actin Cytoskeleton—FGF4—germ cell cancer	0.00033	0.00454	CbGpPWpGaD
Ipratropium bromide—CHRM2—Regulation of Actin Cytoskeleton—FGF4—germ cell cancer	0.000326	0.00449	CbGpPWpGaD
Ipratropium bromide—Urticaria—Methotrexate—germ cell cancer	0.000325	0.00126	CcSEcCtD
Ipratropium bromide—Abdominal pain—Methotrexate—germ cell cancer	0.000324	0.00125	CcSEcCtD
Ipratropium bromide—CYP2D6—testis—germ cell cancer	0.000324	0.0071	CbGeAlD
Ipratropium bromide—CHRM1—G alpha (q) signalling events—OXT—germ cell cancer	0.000323	0.00445	CbGpPWpGaD
Ipratropium bromide—CHRM3—G alpha (q) signalling events—OXT—germ cell cancer	0.000322	0.00443	CbGpPWpGaD
Ipratropium bromide—CHRM5—G alpha (q) signalling events—AVP—germ cell cancer	0.000314	0.00433	CbGpPWpGaD
Ipratropium bromide—SLC22A5—SLC-mediated transmembrane transport—AVP—germ cell cancer	0.000313	0.00431	CbGpPWpGaD
Ipratropium bromide—CHRM5—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	0.000304	0.00418	CbGpPWpGaD
Ipratropium bromide—Hypersensitivity—Methotrexate—germ cell cancer	0.000302	0.00117	CcSEcCtD
Ipratropium bromide—CYP2D6—cerebellum—germ cell cancer	0.000299	0.00656	CbGeAlD
Ipratropium bromide—Asthenia—Methotrexate—germ cell cancer	0.000294	0.00114	CcSEcCtD
Ipratropium bromide—Pruritus—Methotrexate—germ cell cancer	0.00029	0.00112	CcSEcCtD
Ipratropium bromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—OXT—germ cell cancer	0.000289	0.00398	CbGpPWpGaD
Ipratropium bromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—OXT—germ cell cancer	0.000288	0.00396	CbGpPWpGaD
Ipratropium bromide—CHRM5—Regulation of Actin Cytoskeleton—FGFR3—germ cell cancer	0.000287	0.00395	CbGpPWpGaD
Ipratropium bromide—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—germ cell cancer	0.000281	0.00387	CbGpPWpGaD
Ipratropium bromide—Diarrhoea—Methotrexate—germ cell cancer	0.00028	0.00108	CcSEcCtD
Ipratropium bromide—Dizziness—Methotrexate—germ cell cancer	0.000271	0.00105	CcSEcCtD
Ipratropium bromide—Vomiting—Methotrexate—germ cell cancer	0.00026	0.00101	CcSEcCtD
Ipratropium bromide—Rash—Methotrexate—germ cell cancer	0.000258	0.000998	CcSEcCtD
Ipratropium bromide—Dermatitis—Methotrexate—germ cell cancer	0.000258	0.000997	CcSEcCtD
Ipratropium bromide—Headache—Methotrexate—germ cell cancer	0.000256	0.000992	CcSEcCtD
Ipratropium bromide—CHRM2—SIDS Susceptibility Pathways—AVP—germ cell cancer	0.000253	0.00348	CbGpPWpGaD
Ipratropium bromide—Nausea—Methotrexate—germ cell cancer	0.000243	0.00094	CcSEcCtD
Ipratropium bromide—CYP2D6—brain—germ cell cancer	0.000243	0.00533	CbGeAlD
Ipratropium bromide—CHRM5—GPCR ligand binding—OXT—germ cell cancer	0.000231	0.00318	CbGpPWpGaD
Ipratropium bromide—CHRM1—G alpha (q) signalling events—AVP—germ cell cancer	0.000221	0.00305	CbGpPWpGaD
Ipratropium bromide—CHRM3—G alpha (q) signalling events—AVP—germ cell cancer	0.000221	0.00304	CbGpPWpGaD
Ipratropium bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	0.000214	0.00294	CbGpPWpGaD
Ipratropium bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	0.000213	0.00293	CbGpPWpGaD
Ipratropium bromide—SLC22A4—Transmembrane transport of small molecules—AVP—germ cell cancer	0.000212	0.00291	CbGpPWpGaD
Ipratropium bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	0.000211	0.00291	CbGpPWpGaD
Ipratropium bromide—CHRM1—Circadian rythm related genes—AVP—germ cell cancer	0.000209	0.00288	CbGpPWpGaD
Ipratropium bromide—CHRM5—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	0.000208	0.00287	CbGpPWpGaD
Ipratropium bromide—CHRM1—Regulation of Actin Cytoskeleton—FGFR3—germ cell cancer	0.000202	0.00278	CbGpPWpGaD
Ipratropium bromide—CHRM3—Regulation of Actin Cytoskeleton—FGFR3—germ cell cancer	0.000201	0.00277	CbGpPWpGaD
Ipratropium bromide—CHRM2—Regulation of Actin Cytoskeleton—FGFR3—germ cell cancer	0.000199	0.00274	CbGpPWpGaD
Ipratropium bromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—germ cell cancer	0.000198	0.00273	CbGpPWpGaD
Ipratropium bromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—germ cell cancer	0.000197	0.00272	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR ligand binding—OXT—germ cell cancer	0.000163	0.00224	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR ligand binding—OXT—germ cell cancer	0.000162	0.00223	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR ligand binding—OXT—germ cell cancer	0.000161	0.00221	CbGpPWpGaD
Ipratropium bromide—SLC22A5—Transmembrane transport of small molecules—AVP—germ cell cancer	0.000159	0.00219	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR ligand binding—AVP—germ cell cancer	0.000159	0.00218	CbGpPWpGaD
Ipratropium bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	0.000147	0.00202	CbGpPWpGaD
Ipratropium bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	0.000146	0.00201	CbGpPWpGaD
Ipratropium bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	0.000145	0.00199	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—OXT—germ cell cancer	0.000131	0.0018	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—OXT—germ cell cancer	0.000119	0.00163	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR ligand binding—AVP—germ cell cancer	0.000112	0.00154	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR ligand binding—AVP—germ cell cancer	0.000111	0.00153	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR ligand binding—AVP—germ cell cancer	0.00011	0.00152	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—OXT—germ cell cancer	9.21e-05	0.00127	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—OXT—germ cell cancer	9.18e-05	0.00126	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—OXT—germ cell cancer	9.09e-05	0.00125	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—AVP—germ cell cancer	8.96e-05	0.00123	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—SLC2A3—germ cell cancer	8.75e-05	0.0012	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—SLC22A3—germ cell cancer	8.62e-05	0.00119	CbGpPWpGaD
Ipratropium bromide—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—germ cell cancer	8.48e-05	0.00117	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—OXT—germ cell cancer	8.36e-05	0.00115	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—OXT—germ cell cancer	8.33e-05	0.00115	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—OXT—germ cell cancer	8.25e-05	0.00114	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—AVP—germ cell cancer	8.14e-05	0.00112	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—CRABP1—germ cell cancer	7.03e-05	0.000967	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—OXT—germ cell cancer	7.01e-05	0.000965	CbGpPWpGaD
Ipratropium bromide—CHRM1—Circadian rythm related genes—TP53—germ cell cancer	6.59e-05	0.000907	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—AVP—germ cell cancer	6.31e-05	0.000868	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—AVP—germ cell cancer	6.29e-05	0.000866	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—AVP—germ cell cancer	6.23e-05	0.000857	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—FGF4—germ cell cancer	5.99e-05	0.000824	CbGpPWpGaD
Ipratropium bromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—germ cell cancer	5.97e-05	0.000822	CbGpPWpGaD
Ipratropium bromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—germ cell cancer	5.95e-05	0.00082	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—AVP—germ cell cancer	5.73e-05	0.000789	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—AVP—germ cell cancer	5.71e-05	0.000786	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—AVP—germ cell cancer	5.66e-05	0.000778	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—H2AFZ—germ cell cancer	5.35e-05	0.000736	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—SLC2A3—germ cell cancer	5.23e-05	0.00072	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—SLC22A3—germ cell cancer	5.15e-05	0.000709	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—OXT—germ cell cancer	4.94e-05	0.00068	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—OXT—germ cell cancer	4.92e-05	0.000678	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—KITLG—germ cell cancer	4.92e-05	0.000677	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—OXT—germ cell cancer	4.87e-05	0.000671	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—AVP—germ cell cancer	4.81e-05	0.000662	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—FGF4—germ cell cancer	4.22e-05	0.00058	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—FGF4—germ cell cancer	4.2e-05	0.000578	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—CRABP1—germ cell cancer	4.2e-05	0.000578	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—FGF4—germ cell cancer	4.16e-05	0.000573	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—H2AFZ—germ cell cancer	3.76e-05	0.000518	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—H2AFZ—germ cell cancer	3.75e-05	0.000516	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—H2AFZ—germ cell cancer	3.72e-05	0.000511	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—FGFR3—germ cell cancer	3.66e-05	0.000503	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—KITLG—germ cell cancer	3.46e-05	0.000477	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—KITLG—germ cell cancer	3.45e-05	0.000475	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—SLC2A3—germ cell cancer	3.42e-05	0.000471	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—KITLG—germ cell cancer	3.42e-05	0.000471	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—AVP—germ cell cancer	3.38e-05	0.000466	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—AVP—germ cell cancer	3.37e-05	0.000464	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—SLC22A3—germ cell cancer	3.37e-05	0.000464	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—KIT—germ cell cancer	3.36e-05	0.000462	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—AVP—germ cell cancer	3.34e-05	0.00046	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CRABP1—germ cell cancer	2.75e-05	0.000378	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—FGFR3—germ cell cancer	2.57e-05	0.000354	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—FGFR3—germ cell cancer	2.57e-05	0.000353	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—FGFR3—germ cell cancer	2.54e-05	0.00035	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—HRAS—germ cell cancer	2.46e-05	0.000338	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—KIT—germ cell cancer	2.36e-05	0.000325	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—KIT—germ cell cancer	2.36e-05	0.000324	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—KIT—germ cell cancer	2.33e-05	0.000321	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—MYC—germ cell cancer	1.85e-05	0.000254	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—HRAS—germ cell cancer	1.73e-05	0.000238	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—HRAS—germ cell cancer	1.72e-05	0.000237	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—HRAS—germ cell cancer	1.71e-05	0.000235	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—TP53—germ cell cancer	1.52e-05	0.000209	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—HRAS—germ cell cancer	1.45e-05	0.0002	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—MYC—germ cell cancer	1.3e-05	0.000179	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—MYC—germ cell cancer	1.3e-05	0.000178	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—MYC—germ cell cancer	1.28e-05	0.000177	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—TP53—germ cell cancer	1.07e-05	0.000147	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—TP53—germ cell cancer	1.06e-05	0.000147	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—TP53—germ cell cancer	1.05e-05	0.000145	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—HRAS—germ cell cancer	1.02e-05	0.000141	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—HRAS—germ cell cancer	1.02e-05	0.00014	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—HRAS—germ cell cancer	1.01e-05	0.000139	CbGpPWpGaD
